Just been reading the announcement by the Oxford group after large scale trials, showing 70.4% effectiveness with a high proportion (29.6%) potentially demonstrating symptoms still.
The U.K. has access to 100 million doses, it is far cheaper than other solutions and doesn’t need to be stored at -81oC.
1) Is this a win?
2) No news on its reduction in mortality, if any, for those vaccinated who go on to contract. Surely if 0% then contracted and went on to die, this would be a huge win, but without this. See 1.
The U.K. has access to 100 million doses, it is far cheaper than other solutions and doesn’t need to be stored at -81oC.
1) Is this a win?
2) No news on its reduction in mortality, if any, for those vaccinated who go on to contract. Surely if 0% then contracted and went on to die, this would be a huge win, but without this. See 1.